Parafin

Quick links to important sections

Parafin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Parafin

Quick Facts

Property Description
Active Ingredient(s) Magnesium Oxide, Liquid Paraffin
Form Oral tablet, capsule, or liquid suspension
Pharmacological Class Minerals and Electrolytes, Gastrointestinal Agents (Laxative/Antacid)
General Purpose Relieves acid indigestion and promotes bowel regularity
Origin Mineral (MgO) and petroleum distillate (Liquid Paraffin)

What is the Medicinal Identity and Class of Parafin?

Parafin (Magnesium Oxide) is officially classified as a Gastrointestinal Agent with dual therapeutic roles: an Antacid and a Laxative. Its primary active substance is Magnesium Oxide (MgO), which is also an important Mineral and Electrolyte supplement. The product is often distinguished by its combination status, utilizing both components to address digestive issues.

The pharmacological classification is comprehensive because the mineral component is effective in neutralizing stomach acid and functions as an osmotic laxative, while the Liquid Paraffin component is categorized as a stool lubricant. This combined approach is clinically recognized for providing relief in scenarios involving both excess stomach acidity and occasional constipation.


Composition and General Purpose

The medicine's function is dictated by its distinct composition. Magnesium Oxide is an inorganic mineral that provides elemental magnesium and is responsible for the chemical acid neutralization and osmotic hydration actions. Liquid Paraffin, conversely, is a mixture of hydrocarbons derived as a petroleum distillate that acts mechanically.

The general purpose is to provide relief and promote regularity. Magnesium oxide functions as an osmotic agent for managing constipation. This mechanism helps to soften stool and ease its passage by increasing water content in the intestine.

What side effects are possible with Parafin?

Possible Side Effects and Safety Information

The medicine's regulatory safety profile is defined by effects related to its primary components, Magnesium Oxide and Liquid Paraffin, and are classified by frequency and system involvement.

Adverse Reaction Classification

Classification Examples of Reactions
Common Effects Diarrhea, abdominal cramping, nausea, vomiting
Local Effects Anal seepage and irritation (associated with Liquid Paraffin)

Common effects are primarily related to the desired osmotic and laxative actions of the magnesium component, and their occurrence is often noted as being dose-dependent in official safety documentation.

Serious Adverse Reactions

Two principal serious adverse reactions are documented in regulatory labeling. The first is Hypermagnesemia (Magnesium Toxicity), a serious metabolic risk primarily associated with the Magnesium Oxide component. Symptoms of severe toxicity may include hypotension, muscle weakness, and cardiac complications.

The second is Lipoid Pneumonia, a serious risk resulting from the accidental aspiration of the Liquid Paraffin component into the lungs, emphasizing the need for administration constraints to prevent this physical hazard.

Safety Considerations and Restrictions

Regulatory documents emphasize specific restrictions for use. The risk of Hypermagnesemia is explicitly increased in individuals with impaired renal function, necessitating caution in this population. Furthermore, prolonged use of Liquid Paraffin is associated with a specific safety pattern: the potential for reduced absorption of fat-soluble vitamins (A, D, E, K). The medicine is contraindicated in conditions such as intestinal obstruction and abdominal pain of unknown origin.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

The official regulatory profile for Parafin (Magnesium Oxide and Liquid Paraffin) delineates two primary, serious toxicity risks that require immediate medical attention.

The central risk is systemic hypermagnesemia, which affects the nervous and cardiovascular systems. Manifestations documented in official labeling include severe symptoms such as a sharp drop in blood pressure (hypotension), flushing, sweating, and depressed reflexes, including the loss of the patellar reflex. This toxicity can escalate to flaccid paralysis, circulatory collapse, Heart block, and potentially fatal respiratory paralysis at high serum magnesium concentrations.

A separate, life-threatening complication documented for the Liquid Paraffin component is lipoid pneumonia, which has been reported following the aspiration of the substance.

Required Emergency Actions

Regulators explicitly state that immediate medical attention is required upon suspected overdosage due to these severe risks. Documented management protocols include the necessity of providing artificial ventilation and the immediate administration of a calcium salt as an antagonizing agent to counteract the effects of magnesium intoxication. Additionally, monitoring serum magnesium levels and the patient’s clinical status is essential.

Patients with renal impairment (kidney disease) are noted in the official labeling as having an increased risk of severe hypermagnesemia due to impaired magnesium excretion.

Therapeutic Uses of Parafin

What Parafin Treats: Main Uses and Benefits

The combined formulation of Parafin (Magnesium Oxide and Liquid Paraffin) is generally applied across two distinct, interconnected gastrointestinal domains where additional symptomatic support may be needed. These types of agents are commonly used in both antacid and laxative contexts.

The product is relevant for easing symptoms that may cluster in conditions like occasional constipation, sour stomach, and heartburn. It is often used during phases when symptoms become more noticeable.

“The supportive therapeutic benefit is relevant for easing symptoms when acid indigestion becomes noticeable and disruptive, and assists with maintaining functional stability.”

Bowel Regularity and Constipation Symptoms

It supports patients during episodes of heightened discomfort by easing the associated symptoms that create noticeable physiological strain, such as straining and abdominal discomfort. This use may assist with easing the impact of symptoms on routine activities and supports the patient during difficult episodes by easing distress related to stool passage.

Symptomatic Relief of Gastric Acidity

The formulation is commonly used to help manage acute manifestations of gastric hyperacidity. It helps manage and eases the symptoms that cluster into patterns of discomfort, such as heartburn and a sour stomach.


Fact Box: Symptomatic Management Focus

Therapeutic Axis Symptom Category Context
Bowel Management Hard, dry stools, straining, abdominal discomfort Used for occasional or chronic functional constipation
Gastric Acidity Heartburn, sour stomach, acid indigestion Applied during acute episodes of gastric hyperacidity

Regulatory References

  1. NIH MedlinePlus Drug Information on Magnesium Oxide

Eligibility and Restrictions for Use

Who Can and Cannot Use Parafin?

The eligibility for Parafin (Magnesium Oxide and Liquid Paraffin) is strictly defined by regulatory documents, focusing on patient status, organ function, and specific conditions.


Contraindicated Populations

The medicine is contraindicated and must not be used by patients with:

  • Severe Renal Impairment (due to the risk of magnesium accumulation).
  • Gastrointestinal (GI) Obstruction, Perforation, or acute inflammatory GI conditions such as appendicitis.
  • Dysphagia (difficulty swallowing) or conditions that increase the risk of aspiration.
  • Known hypersensitivity to any component of the formulation.

Restricted and Conditional Use

Population/Condition Regulatory Status
Children under 3 to 6 years Not recommended due to specific aspiration risks.
Pregnant or Breastfeeding Women Not recommended for chronic use; only use if deemed necessary by a professional.
Prolonged Use (over 7 days) Not recommended; carries a risk of dependence and reduced fat-soluble vitamin absorption.
Mild to Moderate Renal Impairment Requires caution and monitoring.

Age-Related Eligibility: Adults and adolescents over 12 years are typically considered the standard labeled population. Use in younger children is restricted by the potential hazard of aspiration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for this product is structured around its two active components, Magnesium Oxide and Liquid Paraffin. The resulting pharmacokinetic and pharmacodynamic interactions are documented in regulatory sources and define specific co-administration restrictions.

Absorption-Altering Interactions

The Magnesium Oxide component is officially documented to decrease the systemic exposure of several oral medicines, primarily through chelation and altered gastric pH. This effect is relevant for antibiotics such as Tetracyclines and Fluoroquinolones, as well as other agents including Bisphosphonates, Digoxin, Iron, Chlorpromazine, and Penicillamine. To mitigate reduced efficacy, official labeling requires mandatory time separation: these substances must be administered at least 2 hours before and not less than 6 hours after the magnesium-containing product. The Liquid Paraffin component further presents a documented absorption interference risk, potentially reducing the uptake of fat-soluble vitamins (A, D, E, and K) over time.

Pharmacodynamic and Population Constraints

A pharmacodynamic interaction is documented with agents like Diuretics, NSAIDs, ACE Inhibitors, and ARBs, which may lead to an additive risk of fluid and electrolyte disturbances. The product is officially contraindicated in patients with severe renal impairment (creatinine clearance less than 30 mL/min) because reduced kidney clearance significantly increases the risk of mineral accumulation and hypermagnesemia.

Mechanism of Action

The drug's action is governed by two complementary peripheral, non-systemic mechanisms that modulate distinct physiological processes within the gastrointestinal tract.


Chemical Modulation of Gastric Acidity

This domain involves the direct chemical neutralization of gastric hydrochloric acid ( HCl) by Magnesium Oxide ( MgO). The acid-base reaction consumes H^+ ions, rapidly increasing the stomach's pH. This mechanism modifies the local chemical environment, resulting in the physiological consequence of reduced local acid signaling in the stomach.


Osmotic and Physical Regulation of Fecal Transit

The laxative mechanism combines two distinct actions: The unabsorbed Magnesium ions create a significant osmotic gradient in the colon, drawing water into the lumen and hydrating the stool. Simultaneously, Liquid Paraffin acts as a physical lubricant and emollient, coating the stool and the intestinal wall to reduce frictional resistance. This synergy of osmotic modulation and physical lubrication produces the physiological state of increased stool mass, hydration, and reduced frictional resistance.

Dosage and Administration Information

Parafin (Magnesium Hydroxide/Liquid Paraffin) is designated for oral administration only in its liquid suspension form. The procedure for using the medicine is dictated by specific dosing volumes and a mandated frequency.

Administration is structured as a once-daily regimen. The typical adult dose falls within a range of 15 mL to 30 mL of the suspension. For procedural consistency, the dose may be administered either at bedtime or before breakfast, though the nighttime schedule is frequently employed to align with the product's expected timing of action. The liquid container must be shaken well before the required volume is accurately measured and consumed. Guidelines permit the dose to be mixed with half a glass of water or milk prior to intake to facilitate easier consumption.

Administration Domain Instruction
Adult Dosing Range 15 mL to 30 mL
Dosing Frequency Once daily
Duration Constraint Short-term use only

Administration to specific populations involves certain limitations. The product is not recommended for children under 2 years of age. For pediatric patients aged 2 to 12 years, tiered dose adjustments are mandated, requiring a reduced volume (e.g., 5 mL to 15 mL) compared to the adult regimen. Furthermore, the protocol places a constraint on duration, indicating that the product is intended for short-term use only, and prolonged continuous use without clinical guidance is discouraged. This standardized procedure defines the method of administration.

Recent Clinical Evidence

Research Evidence / Overview of studies for Parafin

Evidence for use in Occasional Constipation and Bowel Regularity

Research exploring the use of Parafin's components for bowel regularity has included short-term Randomized Controlled Trials (RCTs) and comprehensive systematic reviews that examined the osmotic component, Magnesium Oxide, in comparison with placebos or other types of laxatives. These studies primarily focused on the osmotic component in adults experiencing occasional functional constipation. Researchers focused on outcomes related to physical discomfort, such as measuring changes in stool consistency, frequency of spontaneous bowel movements, and patient-reported measures of straining and abdominal discomfort.

Studies conducted during periods of increased symptom activity reported changes in stool parameter measurements following the use of the osmotic agent compared to placebo in short-term settings. Research highlights patterns measured during the study period related to the frequency of complete bowel movements. Findings describe patterns observed in the studies related to how physical discomfort associated with stool passage was reported. However, the specific evidence for the fixed combination—which includes both the osmotic agent and the lubricant (Liquid Paraffin)—is limited and heterogeneous compared to the research on the individual components alone.


Evidence for use in Symptomatic Relief of Gastric Acidity

The antacid action of Parafin's Magnesium Oxide component was evaluated in comparative studies and specialized pharmacodynamic research. These studies explored the rapid physiological changes following administration, specifically monitoring outcomes related to systemic or functional imbalance, such as the change in stomach acid levels. Trials examined individuals with episodic or acute changes in gastric hyperacidity, including symptoms like heartburn and a sour stomach.

Research describing the antacid component reported measurements of changes in stomach acidity over a rapid, short-term period. Trials described patterns related to symptom resolution for acute episodes of heartburn and sour stomach, which was measured shortly after administration. The reported duration of the observed effects on symptoms was transient, often lasting only a few hours. The lubricant component of Parafin is generally not the focus of studies evaluating acid-neutralizing capacity.


Key Evidence Gaps and Areas of Uncertainty

The existing evidence base primarily reflects research exploring short-term symptom changes for both the laxative and antacid uses, typically covering defined time intervals of one to four weeks. Research so far suggests that results apply mainly to the study populations observed over these shorter timeframes. Evidence for the use of Parafin in specific populations, such as children or individuals with specific co-existing medical conditions, is still emerging or limited. Comparative evidence is lacking to fully distinguish the patterns associated with the specific fixed combination (osmotic agent plus lubricant) versus the individual components used separately.

Key Studies & References

  1. Liquid paraffin - ATC/DDD Index (WHO ATC code A06AA01)
  2. Magnesium Hydroxide: MedlinePlus Drug Information (Antacid and Laxative use)
  3. MAGNESIUM OXIDE tablet - DailyMed (Regulatory product label and uses)

Frequently Asked Questions (FAQ)

Common questions about Parafin (FAQ)


Q: What happens if I accidentally take too much Parafin?

In the event of taking too much of this medicine, it is recommended to seek immediate medical attention or contact a Poison Control Center. An overdose can lead to severe side effects primarily linked to magnesium toxicity, which may include symptoms like severe diarrhea, muscle weakness, and, in serious cases, an irregular heartbeat.


Q: Is Parafin used in beauty or skin care products?

The component known as liquid paraffin is widely utilized as an emollient in various cosmetic and skin care formulations. Its function in these products is to help prevent moisture loss and soften the skin. However, the official medicinal formulation is strictly designated for oral (internal) use.


Q: Why is Parafin sometimes listed as an ingredient in ointments?

Liquid paraffin is frequently incorporated into different types of creams and ointments used for dermatological (skin) treatments, such as for dry skin conditions. It acts by creating an occlusive barrier on the skin, which helps to prevent water from evaporating, thus keeping the skin hydrated.


Q: Does Parafin have a strong taste or smell?

The liquid paraffin component itself is generally considered to be practically odorless and tasteless. The specific medicinal product is often designed to be palatable for easier consumption.


Q: Is it normal to experience mild cramping after taking Parafin?

According to official regulatory documents, experiencing mild abdominal cramps and discomfort is noted as a common side effect of this medicine. This is considered a common reaction associated with the laxative action of the medicine.


Q: What should I do if I miss a dose of Parafin?

Official labeling advises against taking a double dose to make up for a missed dose. It recommends continuing with the next scheduled dose at the usual time, according to the prescribed regimen.


Q: Are there side effects specific to topical use of Parafin?

The side effect profile in the patient leaflet is for the oral product. Official product information contains a warning that fabrics in contact with products containing liquid paraffin (e.g., clothing, bedding) should be kept away from naked flames, as they may present a fire hazard.


Q: Does Parafin help with dry skin or eczema?

Liquid paraffin is the emollient component and is the active ingredient in various dermatological treatments used for managing dry skin conditions. It works by forming a protective layer that helps the skin retain moisture, which is the mechanism intended to relieve these conditions.


Q: Does taking Parafin affect my blood pressure?

The use of the standard dose of this product is not typically associated with changes in blood pressure. However, in cases of severe overdose, the resulting high magnesium level (hypermagnesemia) can lead to serious symptoms, which may include hypotension, or dangerously low blood pressure.


Q: Can Parafin interact with herbal supplements?

Regulatory documents advise that antacids and laxatives may potentially interact with various substances. It is recommended that individuals review the use of all herbal and non-herbal supplements with a healthcare professional before taking this medicine.


Q: What are the reported benefits of Parafin wax treatments for joints?

Paraffin wax treatments are recognized in medical policy for their use in physical therapy. They are often applied to the hands or feet to deliver moist heat, which is intended to help relieve pain, stiffness, and discomfort associated with conditions such as arthritis.


Q: What does 'pharmaceutical grade Parafin' mean?

Pharmaceutical grade liquid paraffin is a highly purified version of the substance. It is processed to remove impurities like certain aromatic hydrocarbons, ensuring that it meets strict regulatory purity standards (like USP or BP) for safe ingestion and medical applications.


Q: Can Parafin cause gas or bloating?

Official lists of common side effects include gastrointestinal symptoms. According to regulatory information, potential common reactions can include gas and bloating as the digestive system responds to the actions of the medicine.


Q: Is Parafin the same as mineral oil?

The component known as 'liquid paraffin' is the pharmaceutical name for the substance that acts as a lubricant. This substance is chemically and functionally the same as the product commonly referred to by consumers as 'mineral oil' when used in medical and food-grade applications.


Q: Can elderly people use Parafin without special concerns?

Official labeling does not impose specific restrictions or cautions that apply universally to the elderly as a group. However, use in this population is advised only after confirming there are no underlying conditions, such as existing severe renal impairment, which is a major contraindication.


Q: Can Parafin be used for lubricating medical devices?

Liquid paraffin is a physical lubricant and is often used as a base for lubricating agents in medicine. However, the regulatory information for this specific oral medicine is restricted to its internal function as a stool lubricant and its antacid properties.


Q: Can Parafin be mixed with juice or water?

The standard administration procedure permits the dose of the liquid suspension to be mixed with half a glass of water or milk to make it easier to swallow. While mixing with juice is a common patient practice, the official prescribing information explicitly mentions mixing the dose with water or milk.


Q: Is Parafin available without a prescription?

While regulatory sources confirm this product is a licensed medicine, they do not explicitly state its dispensing status (e.g., whether it is an over-the-counter or prescription product). This determination is often governed by local laws and pharmacy regulations.


Q: Can pregnant women use Parafin?

Regulatory guidelines state that it is generally not recommended for chronic use during pregnancy or breastfeeding, and its use should be reserved for cases where a healthcare professional determines the potential benefit is necessary.


Q: Does Parafin cause dependency if used frequently?

Official warnings caution against prolonged or continuous use without professional guidance due to the associated risk of developing dependence on laxatives, as well as the potential for reduced vitamin absorption.


Q: Is it true that Parafin can cause leakage?

Yes, official safety information lists anal seepage and irritation as potential local side effects. Anal seepage refers to the involuntary passing or 'leakage' of the paraffin component from the rectum, which is associated with the lubricating action of the liquid paraffin.

How should Parafin be stored and disposed of?

The storage and disposal of medicinal paraffin products must strictly adhere to regulatory requirements to maintain product stability and ensure public safety.

Storage Requirements

Condition Type Mandatory Requirement
Temperature Store below 25 C and do not expose to heat.
Protection Keep the medicine in a dry place, protected from light and moisture.
Packaging Keep the product in its original container and keep the container tightly closed.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Official labeling strictly prohibits disposing of the medicine via wastewater or household waste. Unused or expired product must be discarded in accordance with local requirements; patients are instructed to consult their pharmacist for proper disposal methods. For topical paraffin products, a fire hazard warning is mandatory, advising users not to smoke or go near naked flames if the product is in contact with fabrics (clothing, bedding).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Parafin found in:

A-Z Index: